Is Pfizer's Attractive Valuation Enough to Invest in the Stock?

Oct 22, 2024 · Drug giant Pfizer PFE is trading quite cheap after its stock took a beating last year once the pandemic ended.The stock is trading at a discount to the industry and is also trading below its 5 ...

40%
OFF

What To Expect From PFE Stock In 2025? - Forbes

2 weeks from now

13 hours ago · We think PFE stock is now undervalued. We estimate Pfizer’s valuation to be around $36 per share, reflecting around 40% upside from its current levels. The optimism …

forbes.com

8%
OFF

Should You Buy, Sell Or Hold Pfizer Stock Before Q3 Earnings?

2 weeks from now

Oct 23, 2024 · PFE’s Price Performance & Valuation. In the past six months, Pfizer’s stock has risen 9.8% compared with an increase of 7.8% for the industry. The stock has also …

zacks.com

4%
OFF

Pfizer: My Top Play In 2025 Using Dogs Of The Dow Strategy

2 weeks from now

3 days ago · The 'Dogs of the Dow' strategy can be applied to Pfizer in 2025 for its 6.4% dividend and a former 'Dog.'. PFE's growth recovery, historical cheap valuation, and positive investment …

seekingalpha.com

30%
OFF

Is Pfizer A Buy Right Now Or A Value Trap? - Nasdaq

2 weeks from now

Oct 3, 2024 · All of this has weighed on Pfizer's stock performance, leaving the shares down more than 30% over the past three years. Valuation has halved from a year ago, with Pfizer shares …

nasdaq.com

30%
OFF

Is Pfizer A Buy Right Now Or A Value Trap? - Yahoo Finance

2 weeks from now

Oct 3, 2024 · All of this has weighed on Pfizer's stock performance, leaving the shares down more than 30% over the past three years. Valuation has halved from a year ago, with Pfizer shares …

yahoo.com

$36.00
OFF

Pfizer’s Growth Potential And Strategic Focus ... - Markets Insider

2 weeks from now

2 days ago · Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer (PFE – Research Report) and keeping the price target at $36.00. Discover outperforming stocks and …

businessinsider.com

73%
OFF

Why I'm Considering Leaning Heavily Into Pfizer - The Motley Fool

2 weeks from now

Oct 16, 2024 · A high-yield dividend stock with long-term potential. Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% …

fool.com

85%
OFF

PFE Quantitative Stock Analysis - Nasdaq

2 weeks from now

1 day ago · PFIZER INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 85% based on the firm’s underlying fundamentals and the stock’s …

nasdaq.com

FAQs about Is Pfizer's Attractive Valuation Enough to Invest in the Stock? Coupon?

Is Pfizer (PFE) stock undervalued?

We think PFE stock is now undervalued. We estimate Pfizer’s valuation to be around $36 per share, reflecting around 40% upside from its current levels. The optimism stems from its attractive valuation. ...

Is Pfizer PFE a good stock to buy?

Drug giant Pfizer PFE is trading quite cheap after its stock took a beating last year once the pandemic ended. The stock is trading at a discount to the industry and is also trading below its 5-year mean. ...

Is Pfizer a good stock to buy in 2025?

It is more evident that PFE has a low valuation with PEG Non-GAAP at a substantial -37.99% discount with the Sector Median. I think the current valuations could make Pfizer very noticeable in the volatile and overvalued market in 2025 if the S&P 500 earnings growth cannot keep up pace with the expectation to justify the high market valuation. ...

Is Pfizer a good stock for long-term investors?

The company is also cutting costs, targeting at least $4 billion in net savings by the end of 2024. Patience may be required as pipeline programs advance and COVID headwinds abate. However, for long-term investors, Pfizer's combination of high yield, low valuation, and pipeline potential is compelling. ...

Is Pfizer a value trap?

Thanks to its rock-bottom valuation and sky-high yield, Pfizer has become a hotly debated topic in the investing community. Some investors see the stock as deeply undervalued, reflecting an overly skeptical market. In contrast, others view the drugmaker's shares as a value trap. ...

Is Pfizer stock underappreciated?

Pfizer appears to be on its way to achieving these goals. However, Pfizer remains underappreciated by investors. The stock received only a minor boost from all of its positive developments in recent weeks. Shares are still down close to 35% below the high set in late 2021. Pfizer stock currently trades at only 12 times expected earnings. ...